Haemophilus influenzae infection primary prevention

Revision as of 15:39, 24 April 2017 by Mehdi Pahlavani (talk | contribs)
Jump to navigation Jump to search

Haemophilus influenzae infection Main page

Patient Information

Overview

Causes

Classification

Pneumonia
Bacteremia
Meningitis
Epiglottitis
Cellulitis
arthritis
Otitis media
Conjunctivitis

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Protection against Haemophilus influenzae type b (Hib) is not specific to the needs of travelling children. In many countries Hib vaccine is routinely administered in childhood. Missing vaccinations in travellers <5 years of age should be offered according to national recommendations.

Primary Prevention

Risk for travellers

The risk is likely to be increased in an environment of low Hib vaccination coverage.

Vaccine

Polysaccharide-protein conjugate vaccine. In infants 2 or 3 primary doses should be administered, the first dose at 6 weeks of age or soon thereafter. Hib vaccine is not required for healthy children older than 5 years.

References

Template:WikiDoc Sources